DRIO (DarioHealth) Short Interest


DRIO DarioHealth Corp DRIO
62 GF Score
Price $6.06
GF Value $7.15
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is DarioHealth Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

DRIO vs BEAT, ONMD, VASO: Short Interest Comparison

For the Health Information Services subindustry, DarioHealth's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DarioHealth Short Interest vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DarioHealth's Short Interest distribution charts can be found below:

* The bar in red indicates where DarioHealth's Short Interest falls into.


DRIO
62GF Score
DarioHealth Corp DRIO
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is DarioHealth (DRIO) Overvalued in 2026?

Based on GuruFocus' analysis, DarioHealth stock appears to be undervalued. The current stock price of $6.06 is trading 15.2% below its estimated GF Value™ of $7.15. GuruFocus considers DarioHealth to be Modestly Undervalued.

Key valuation signals for DRIO:

  • Short Interest:
  • GF Value™: $7.15 vs. price of $6.06 (15.2% below fair value)
  • GF Score™: 62/100 with 4 warning signs

No single metric tells the full story. See the DRIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DarioHealth Business Description

Address 322 West 57th Street, New York, NY, USA, 10019
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
62GF Score

Get the complete analysis for DRIO

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.06
Price
$7.15
GF Value